đź’¨ Abstract
Novo Nordisk and Valo Health have expanded their 2023 agreement to develop new treatments for cardiometabolic diseases using AI. The partnership aims to develop up to 20 drugs for obesity, type 2 diabetes, and cardiovascular diseases. The deal could potentially yield Valo near-term payments of up to $190 million and milestone payments of $4.6
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Transparency and awareness are crucial to avoid health insurance claim rejections: Experts
Jeffrey Epstein's abuse survivor, Virginia Giuffre, dies at 41
Pakistan ISI is killing Hindus for 45 years. To turn India into a nation at war with itself
Vinay Narwal’s Karnal school wanted him to address students in Navy uniform
Vatican concludes Pope Francis' lying in state with sealing of coffin
Pakistan military resorts to unprovoked firing along LoC
UN Security Council condemns in 'strongest terms' J&K terror attack, underlines need to hold perpetrators accountable
Pakistan's Army Attache in UK makes throat slit gesture at Indian community protestors
Employment in India grown faster than working-age population: World Bank report
UN Security Council strongly condemns Jammu and Kashmir terror attack, calls for justice
Powered by MessengerX.io